İrem Doğan

427 total citations
22 papers, 272 citations indexed

About

İrem Doğan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, İrem Doğan has authored 22 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in İrem Doğan's work include Cancer-related Molecular Pathways (8 papers), Metabolism, Diabetes, and Cancer (4 papers) and Pancreatic function and diabetes (3 papers). İrem Doğan is often cited by papers focused on Cancer-related Molecular Pathways (8 papers), Metabolism, Diabetes, and Cancer (4 papers) and Pancreatic function and diabetes (3 papers). İrem Doğan collaborates with scholars based in Türkiye and United States. İrem Doğan's co-authors include Abdullah Ekmekçi, Tuba Çandar, Ahmet Cumaoğlu, Aysel Arıcıoğlu, Ece Konaç, Hacer İlke Önen, Selda Demırtaş, Can Öztürk, Phillip A. Dennis and Ahmet Selim Yurdakul and has published in prestigious journals such as Journal of Cellular Biochemistry, Experimental Biology and Medicine and Biochimie.

In The Last Decade

İrem Doğan

20 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
İrem Doğan Türkiye 10 147 79 54 37 36 22 272
Jee Hyun Rho South Korea 12 189 1.3× 36 0.5× 41 0.8× 19 0.5× 42 1.2× 23 364
Xiaochun Lin China 12 201 1.4× 48 0.6× 104 1.9× 27 0.7× 50 1.4× 35 406
A.-A. Weber Germany 12 133 0.9× 37 0.5× 46 0.9× 15 0.4× 27 0.8× 17 612
Kyle T. Keyes United States 7 206 1.4× 51 0.6× 82 1.5× 66 1.8× 29 0.8× 7 492
Yan Yao China 10 179 1.2× 75 0.9× 49 0.9× 44 1.2× 12 0.3× 20 352
Bu‐Shan Xie China 11 200 1.4× 34 0.4× 70 1.3× 25 0.7× 27 0.8× 15 343
Jer-Young Liou Taiwan 10 164 1.1× 31 0.4× 74 1.4× 37 1.0× 38 1.1× 13 403
Hong Lu China 12 202 1.4× 59 0.7× 37 0.7× 10 0.3× 24 0.7× 25 392

Countries citing papers authored by İrem Doğan

Since Specialization
Citations

This map shows the geographic impact of İrem Doğan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by İrem Doğan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites İrem Doğan more than expected).

Fields of papers citing papers by İrem Doğan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by İrem Doğan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by İrem Doğan. The network helps show where İrem Doğan may publish in the future.

Co-authorship network of co-authors of İrem Doğan

This figure shows the co-authorship network connecting the top 25 collaborators of İrem Doğan. A scholar is included among the top collaborators of İrem Doğan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with İrem Doğan. İrem Doğan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doğan, İrem, et al.. (2025). Forgotten Intrauterine Device Causing Postmenopausal Endometritis: A Case Report. Cureus. 17(11). e97856–e97856.
2.
3.
Doğan, İrem, et al.. (2022). Metformin resistant MDA-MB-468 cells exhibit EMT-like phenotype and increased migration capacity. Molecular Biology Reports. 49(7). 5973–5984. 5 indexed citations
4.
Doğan, İrem, et al.. (2022). Effects of thiostrepton alone or in combination with selumetinib on triple-negative breast cancer metastasis. Molecular Biology Reports. 49(11). 10387–10397. 6 indexed citations
5.
6.
Doğan, İrem, et al.. (2019). The outcomes of an impaired powerhouse in KRAS mutant lung adenocarcinoma cells by Elesclomol. Journal of Cellular Biochemistry. 120(6). 10564–10571. 7 indexed citations
7.
Doğan, İrem, et al.. (2018). Potential effects of metformin in DNA BER system based on oxidative status in type 2 diabetes. Biochimie. 154. 62–68. 33 indexed citations
8.
Doğan, İrem, et al.. (2018). Do MCF7 cells cope with metformin treatment under energetic stress in low glucose conditions?. Molecular Biology Reports. 45(3). 195–201. 2 indexed citations
9.
Doğan, İrem, et al.. (2017). Health-related quality of life in non-paraplegic (ambulatory) children with myelomeningocele. Child s Nervous System. 33(11). 1997–2002. 1 indexed citations
10.
Doğan, İrem, et al.. (2017). Role of metformin on base excision repair pathway in p53 wild-type H2009 and HepG2 cancer cells. Human & Experimental Toxicology. 37(9). 909–919. 10 indexed citations
11.
Doğan, İrem, et al.. (2016). Flavopiridol Induces Apoptosis via Mitochondrial Pathway in B16F10 Murine Melanoma Cells and a Subcutaneous Melanoma Tumor Model.. PubMed. 24(1). 2–12. 5 indexed citations
12.
Doğan, İrem. (2016). Molecular Mechanisms in Formation and Progression of Malignant Melanoma. Turkish Journal of Dermatology. 184–188.
13.
Doğan, İrem, et al.. (2016). Flavopiridol's antiproliferative effects in glioblastoma multiforme. Journal of Cancer Research and Therapeutics. 12(2). 811–817. 13 indexed citations
14.
Doğan, İrem, et al.. (2015). The comparison between dual inhibition of mTOR with MAPK and PI3K signaling pathways in KRAS mutant NSCLC cell lines. Tumor Biology. 36(12). 9339–9345. 12 indexed citations
15.
Doğan, İrem, Shigeru Kawabata, Emily Anne Smith Bergbower, et al.. (2014). SOX2 expression is an early event in a murine model of EGFR mutant lung cancer and promotes proliferation of a subset of EGFR mutant lung adenocarcinoma cell lines. Lung Cancer. 85(1). 1–6. 25 indexed citations
16.
Maier, Colleen R., et al.. (2011). Nicotine Does Not Enhance Tumorigenesis in Mutant K - Ras –Driven Mouse Models of Lung Cancer. Cancer Prevention Research. 4(11). 1743–1751. 20 indexed citations
17.
Menevşe, Sevda, İrem Doğan, Ebru Alp, et al.. (2011). Investigation of Ocular Neovascularization–Related Genes and Oxidative Stress in Diabetic Rat Eye Tissues After Resveratrol Treatment. Journal of Medicinal Food. 15(4). 391–398. 32 indexed citations
18.
Doğan, İrem, Ahmet Cumaoğlu, Aysel Arıcıoğlu, & Abdullah Ekmekçi. (2010). Inhibition of ErbB2 by Herceptin reduces viability and survival, induces apoptosis and oxidative stress in Calu-3 cell line. Molecular and Cellular Biochemistry. 347(1-2). 41–51. 24 indexed citations
19.
Konaç, Ece, et al.. (2009). Genetic Variations in the Hypoxia-Inducible Factor-1αGene and Lung Cancer. Experimental Biology and Medicine. 234(9). 1109–1116. 27 indexed citations
20.
Doğan, İrem, Abdullah Ekmekçi, Ahmet Selim Yurdakul, et al.. (2008). Polymorphisms in the Aurora-A Gene Is Not Associated with Lung Cancer in the Turkish Population. DNA and Cell Biology. 27(8). 443–448. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jee Hyun Rho Breakdown of academic impact, for papers by Xiaochun Lin Breakdown of academic impact, for papers by A.-A. Weber Breakdown of academic impact, for papers by Kyle T. Keyes Breakdown of academic impact, for papers by Yan Yao Breakdown of academic impact, for papers by Bu‐Shan Xie Breakdown of academic impact, for papers by Jer-Young Liou Breakdown of academic impact, for papers by Hong Lu
Rankless by CCL
2026